Open AccessTreating AML Patients Ineligible for Intensive Chemotherapy
Author(s) -
Richard Simoneaux
Publication year - 2021
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000789436.14885.6a
Subject(s) - venetoclax , cytarabine , azacitidine , medicine , mitoxantrone , decitabine , daunorubicin , oncology , chemotherapy , myeloid leukemia , anthracycline , leukemia , cancer , chronic lymphocytic leukemia , breast cancer , biochemistry , gene expression , chemistry , dna methylation , gene